NCT06626919 2026-02-25
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Phase 1 Recruiting
Clinical Trials
5 trialsNCT05116137 2024-03-12
RESIST
Nova Scotia Health Authority
Phase NA Enrolling by invitation
NCT01047163 2016-04-27
Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy
University of Nottingham
Completed
NCT00954746 2015-06-16
Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
Endo Pharmaceuticals
Completed
NCT01395563 2015-03-13
STOPC
German Cancer Research Center
Phase NA Withdrawn